Philippe Halfon
8Patents
1h-index
13Co-inventors
40Inventor score
Filing activity: Oct 28, 2011 → Aug 1, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8575195B2 | Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent | Human Necessities | 2 | Active |
| US8729014B2 | Specific HCV NS3 protease inhibitors | Human Necessities | 1 | Active |
| US10577362B2 | Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases | Human Necessities | 0 | Active |
| US11261189B2 | Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins B (CTSB), L (CTSL) and D (CTSD) related diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US8912141B2 | Treatment of hepatitis C virus | Human Necessities | 0 | Active |
| US10179770B2 | Quinolines derivatives as novel anticancer agents | Chemistry; Metallurgy | 0 | Active |
| US8987302B2 | Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent | Human Necessities | 0 | Active |
| US10722505B2 | Substituted 2,4 diamino-quinoline as new anticancer agents | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.